Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis

Recent phase II pilot clinical trials suggested that tauro-urso-deoxycholic acid (TUDCA) might slow functional decline and increase survival in patients with amyotrophic lateral sclerosis (ALS). We performed a multivariate analysis of the original TUDCA cohort to better define the treatment effect a...

Descripción completa

Detalles Bibliográficos
Autores principales: Reggiardo, Giorgio, Lo Giudice, Maria, Lalli, Stefania, Rinaldi, Gilberto, Albanese, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157207/
https://www.ncbi.nlm.nih.gov/pubmed/37153676
http://dx.doi.org/10.3389/fneur.2023.1163855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157207/
https://www.ncbi.nlm.nih.gov/pubmed/37153676
http://dx.doi.org/10.3389/fneur.2023.1163855

Ejemplares similares